The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Rheumatology Care: Access & Affordability

Rheumatology Care: Access & Affordability

June 13, 2021 • By Vanessa Caceres

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Specialty pharmacy utilizers

Specialty pharmacy utilizers
Source: CVS Health Enterprise Analytics

Presenters at the Access in Rheumatology meeting held in advance of the ACR’s State-of-the-Art Clinical Symposium took a deep dive into the access challenges faced by rheumatology patients and discussed possible solutions.

You Might Also Like
  • ACR Puts Forward Principles on Patient Access to Care
  • Protect Your Patients’ Access to Care & Treatment
  • Legislative Successes in 2017: Rheumatologists lead the push in Congress for access to care, research funding, transparency in drug pricing
Explore This Issue
June 2021
Also By This Author
  • What Diet to Recommend to Patients with Rheumatoid Arthritis?

Treatment

At least until 2026, prescription drug spending will exceed the U.S. gross domestic product (GDP) and health spending, said rheumatologist Colin C. Edgerton, MD, American Rheumatology Network, Charleston, S.C. Much of that spending is attributed to the purchase of specialty drugs, including those prescribed by rheumatologists.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

High drug prices and recent drug shortages, such as for hydroxychloroquine and methotrexate, are among the healthcare access challenges rheumatology patients face. One example Dr. Edgerton discussed was a 100% increase in the price of adalimumab over the past five years. The trends of higher drug prices and shortages lead to prescription abandonment and lack of adherence, he said.

High drug costs have led to an increase in prior authorization requirements, with one American Medical Association survey cited by Dr. Edgerton showing two hours of physician paperwork spent for every hour of direct patient care. “It’s a leading source of physician dissatisfaction,” he said.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Edgerton outlined the growth of value-based medicine that focuses on higher quality and lower costs, even for some rheuma­tology drugs and shared barriers that rheumatologists often face when tracking outcomes, due to smaller practice sizes and the financials involved with tracking analytics.

Specialty Drug Prices

Dr. Chaguturu

Dr. Chaguturu

Sree Chaguturu, MD, chief medical officer for CVS Caremark, offered a perspective on the role of pharmacy benefit managers and shared more data on the high costs involved with specialty drugs. One example: Specialty medications are used by only 2.5% of the total population, but account for about 50% of the total drug spending. The majority of those costs are incurred by those who continue on therapy rather than newer users, he explained.

The use of specialty medications will only increase going forward. Of 537 drugs in the drug pipeline over the next three years, 355 are specialty drugs. There also are 283 existing drugs that will have new specialty indications, Dr. Chaguturu said. “This is fantastic for new opportunities to manage comorbidities and patient conditions, but sponsors want to make sure there is appropriate access and pricing.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Gene therapy and hyperinflation are adding to costly therapies, but biosimilars are mitigating these by creating competition and potentially lowering costs, Dr. Chaguturu said.

The entry of biosimilars to the market has been slow in the U.S. compared to Europe, but will eventually assist with cost savings, Dr. Edgerton said.

Pages: 1 2 3 | Single Page

Filed Under: Legislation & Advocacy, Patient Perspective Tagged With: Access to care, costIssue: June 2021

You Might Also Like:
  • ACR Puts Forward Principles on Patient Access to Care
  • Protect Your Patients’ Access to Care & Treatment
  • Legislative Successes in 2017: Rheumatologists lead the push in Congress for access to care, research funding, transparency in drug pricing
  • ACR & NPF Highlight Medicare Access Challenges in Capitol Hill Briefing

Patient & Caregiver Resources

Find a rheumatology provider. Learn about your condition and how to live with it. English and Spanish language resources.

View Patient & Caregiver Resources »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)